Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana-Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-4790Fax+1 617-632-5786
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
University of ChicagoResidency, Internal Medicine, 1979 - 1982
University of Minnesota Medical SchoolClass of 1979
Certifications & Licensure
MA State Medical License 1998 - 2027
MD State Medical License 1983 - 2026
NH State Medical License 2024 - 2024
IL State Medical License 1980 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Start of enrollment: 1994 Mar 01
- High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations Start of enrollment: 2006 Jun 01
- Dasatinib in Advanced Squamous Cell Lung Cancer Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy +/- chemotherapy in nonsquamous non-small ce...Malini M Gandhi, Arielle Elkrief, Catherine Gutierrez Moore, Biagio Ricciuti, Joao V Alessi
Journal of Thoracic Oncology. 2025-01-24 - A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors.Kimberly Perez, Matthew H Kulke, Hui Zheng, Jill Allen, Jeffrey Clark
The Oncologist. 2025-01-17 - Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study.Ibiayi Dagogo-Jack, Alissa J Cooper, Bruce E Johnson, Justin F Gainor, Jessica J Lin
Lung Cancer. 2025-01-01
Journal Articles
- Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer PopulationKhanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
Press Mentions
ASCO Elects Dana-Farber/Brigham and Women's Elizabeth a. Mittendorf, MD, PhD, as 2026-2027 PresidentDecember 18th, 2024- Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024September 11th, 2024
- ‘A Million Data Points’: A 30-Year Long Lung Cancer Study Meets AIApril 6th, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
